Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,998 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, not recruiting

Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy

NCT02889523

Conditions
DLBCL, Follicular Lymphoma, Hemic and Lymphatic Diseases, +9 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • CHU de Liege Liège, Belgium
  • CHRU Mont Godinne Yvoir, Belgium
  • Centre Hospitalier Victor Dupouy Argenteuil, France
View all 31 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma

NCT05646836

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Peter Maccallum Cancer Centre Melbourne, Victoria, Australia
  • Alfred Hospital Melbourne, Victoria, Australia
  • Sygehus Lillebaelt - Vejle Sygehus Vejle, Denmark
View all 13 locations
View Trial Details
Active, not recruiting

Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas

NCT03220022

Conditions
AIDS-related Lymphoma, Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, +12 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Memorial Hospital West Pembroke Pines, Florida, United States
View all 19 locations
View Trial Details
Active, not recruiting

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants

NCT05831111

Conditions
DNA Virus Infections, Epstein-Barr Virus Infection, Epstein-Barr Virus Infections, +12 more
Locations
  • Pinnacle Research Group, LLC Anniston, Alabama, United States
  • Noble Clinical Research Tucson, Arizona, United States
  • Marvel Clinical Research Huntington Beach, California, United States
  • Tekton Research Longmont, Colorado, United States
View all 34 locations
View Trial Details
Active, not recruiting

A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

NCT04224493

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Southern Cancer Center Mobile, Alabama, United States
  • Arizona Oncology Associates - Tuscon-Rusadill Road Tucson, Arizona, United States
  • TOI - Clinical Research Cerritos, California, United States
  • UCSF Fresno Clovis, California, United States
View all 204 locations
View Trial Details
Active, not recruiting

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors

NCT06970743

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Peking University Peoples Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 56 locations
View Trial Details

Related conditions